New insider activity at USANA Health ( (USNA) ) has taken place on August 8, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Gilbert Fuller has recently sold 1,058 shares of USANA Health stock, amounting to a total transaction value of $30,787.
Recent Updates on USNA stock
USANA Health Sciences Inc. reported a strong financial performance in its Q2 2025 earnings, with an 11% increase in net sales year-over-year, reaching $236 million, although net earnings slightly declined to $9.7 million. The company maintained its fiscal year 2025 outlook, expecting net sales growth of 8% to 17%. Key strategic initiatives included enhanced sales incentives and a rebranding of sales leaders to ‘Brand Partners.’ Despite challenges such as a decline in active customers in China and other regions, USANA’s Hiya business showed strong growth, bolstered by a new partnership with Disney. The company ended the quarter with a strong balance sheet, including $151 million in cash and no debt, and continued its share repurchase program. Analysts have a neutral outlook on the stock due to mixed technical indicators and concerns over declining revenues and net profit margins, despite the company’s positive earnings call and strategic growth plans.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Outperform.
USANA Health benefits from strong earnings performance and strategic initiatives, though it faces financial challenges with declining revenues and customer numbers. The technical outlook is mixed, and valuation is moderate. The positive momentum from recent earnings and initiatives supports a stable outlook.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
YTD Price Performance: -20.34%
Average Trading Volume: 152,061
Technical Sentiment Signal: Strong Sell
Current Market Cap: $530.6M